Two-period crossover study investigating the clinical pharmacokinetic similarity of the etanercept biosimilar CHS 0214 to Enbrel in healthy volunteers
Latest Information Update: 12 Nov 2013
At a glance
- Drugs Etanercept (Primary)
- Indications Autoimmune disorders; Plaque psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Coherus Biosciences
- 12 Nov 2013 New trial record
- 28 Oct 2013 Results published in the Media Release.